English | Español

Abbott Laboratories
Erianne Leatherman | Mar 24, 2017

Arriva Medical considering appeal options following court's ruling

Gene Johnson | Mar 19, 2017

Respiratory infection test now available to doctors, clinics
Gene Johnson | Mar 17, 2017

FDA approves catheter designed to treat type of irregular heartbeat
Dorothy Goodin | Feb 5, 2017

Abbott's newest pacemaker allows for MRI testing
Dorothy Goodin | Feb 5, 2017

Abbott's BurstDR lessens pain, improves quality of life
Keri Carbaugh | Feb 3, 2017

European hospitals urged to diagnose C. difficile infection accurately
Keri Carbaugh | Jan 20, 2017

U.S. physicians cleared to use precision cardiac mapping system
Keri Carbaugh | Jan 12, 2017

Alere Forensics receives ABFT accreditation

Trending
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards